Modifications of cell-cycle induced by dpr, a new platinum-triamine complex containing procaine

Area of Science:

• Oncology
• Pharmacology
• Cell Biology

Background:

• Platinum-triamine complexes represent a novel class of anticancer agents.
• Procaine, a local anesthetic, is incorporated as a ligand in the novel platinum complex DPR.
• Understanding the cellular effects of novel platinum compounds is crucial for cancer therapy development.

Purpose of the Study:

• To compare the effects of DPR and cisplatin (cis-DDP) on P388 murine leukemic cells.
• To investigate the influence of these compounds on cell cycle phases and apoptosis induction.
• To evaluate the cytotoxic activity and DNA synthesis inhibition of DPR versus cis-DDP.

Main Methods:

• In vitro exposure of P388 leukemic cells to DPR and cis-DDP for 24 hours.
• Assessment of thymidine uptake to measure DNA synthesis inhibition.
• Trypan blue dye exclusion assay and flow cytometry to evaluate cytotoxicity and apoptosis.

Main Results:

• DPR and cis-DDP demonstrated comparable cytotoxic activity and inhibition of DNA synthesis.
• Both compounds induced similar modifications in cell cycle progression.
• Apoptosis was similarly induced by equivalent concentrations and exposure times of DPR and cis-DDP.

Conclusions:

• DPR exhibits comparable efficacy to cisplatin in P388 leukemic cells.
• The novel platinum-triamine complex DPR shows similar effects on cell cycle and apoptosis as cis-DDP.
• DPR represents a potential candidate for further investigation in cancer treatment.